Indicators

Markets:

News

Latest News about MDMA/assisted therapy

Recent news which mentions MDMA/assisted therapy

Veterans Deserve Access To Life-Changing Psychedelics Therapy: A Vital Solution For PTSD And Healing

November 11, 2024

FDA Public Meeting Reveals Federal Support For Psychedelics In PTSD Care

October 31, 2024

Veterans Affairs Eyes Funding For New MDMA-PTSD Trial After FDA Setback

October 24, 2024

PharmAla Biotech To Supply LaNeo MDMA For Mt. Sinai Clinical Trial

October 21, 2024

PharmAla Biotech To Supply University Of Texas, San Antonio For Clinical Trial

October 08, 2024

Sam Altman's Psychedelic Breakthrough: How The OpenAI Visionary Plans To Transform Mental Health Care With MDMA

September 25, 2024

MDMA Therapy For PTSD Faces FDA Delay: Are There Other Ways Forward?

September 12, 2024

Multidisciplinary Association For Psychedelic Studies Eyes State-Level Legalization After FDA Denial Of MDMA Therapy

September 11, 2024

Drug Science Research Group And London College Team Up To Advance MDMA-Assisted Therapy

September 04, 2024

Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD

August 29, 2024

Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment

August 16, 2024

MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site

August 13, 2024

Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles

August 07, 2024

Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms

July 29, 2024

Two Top Biotechs Forge MDMA Supply Deals For Clinical Research

March 26, 2024

Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment

January 04, 2024

Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application

December 12, 2023

Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program

September 25, 2023

Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News

September 15, 2023

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next

September 14, 2023

Fluence Inks Deal To Bring Brazil's Psychedelic Therapy Training Scene To New Heights

July 26, 2023

MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University

June 20, 2023

Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study

June 16, 2023

Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia

June 12, 2023

Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia

June 09, 2023

EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps

April 19, 2023

Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies

April 11, 2023

MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update

April 03, 2023

MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production

March 02, 2023

Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions

February 07, 2023

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.